[HTML][HTML] Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis

RR Ling, K Ramanathan, FL Tan, BC Tai… - The Lancet …, 2022 - thelancet.com
Background Myopericarditis is a rare complication of vaccination. However, there have been
increasing reports of myopericarditis following COVID-19 vaccination, especially among …

Can a combination of vaccination and face mask wearing contain the COVID‐19 pandemic?

H Brüssow, S Zuber - Microbial Biotechnology, 2022 - Wiley Online Library
The COVID‐19 pandemic is going into its third year with Europe again being the focus of
major epidemic activity. The present review tries to answer the question whether one can …

Public health impact of covid-19 vaccines in the US: observational study

AB Suthar, J Wang, V Seffren, RE Wiegand, S Griffing… - Bmj, 2022 - bmj.com
Objective To evaluate the impact of vaccine scale-up on population level covid-19 mortality
and incidence in the United States. Design Observational study. Setting US county level …

Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the …

RE Wiegand, Y Deng, X Deng, A Lee… - The Lancet Regional …, 2023 - thelancet.com
Background Sero-surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) can reveal trends and differences in subgroups and capture undetected or …

COVID-19 vaccine hesitancy cannot fully explain disparities in vaccination coverage across the contiguous United States

S Hu, C Xiong, Q Li, Z Wang, Y Jiang - Vaccine, 2022 - Elsevier
Vaccine hesitancy has been identified as a major obstacle preventing comprehensive
coverage against the COVID-19 pandemic. However, few studies have analyzed the …

The benefits of large scale covid-19 vaccination

C Dye - bmj, 2022 - bmj.com
The first covid-19 vaccines were administered under emergency use authorisation in
December 2020, just one year into the pandemic, a “miracle” of pharmaceutical innovation …

Incidence and risk factors of myocarditis in hospitalized patients with COVID‐19

K Keller, I Sagoschen, S Konstantinides… - Journal of medical …, 2023 - Wiley Online Library
Myocarditis as cardiac involvement in coronavirus disease 2019 (COVID‐19)‐infection is
well known. Real‐world data about incidence in hospitalized COVID‐19‐patients and risk …

The impact of COVID-19 vaccination on case fatality rates in a city in Southern Brazil

H Passarelli-Araujo, H Pott-Junior, AM Susuki… - American journal of …, 2022 - Elsevier
Background Recent studies have established that vaccination plays a significant role in
reducing COVID-19-related deaths. Here, we investigated differences in COVID-19 case …

[HTML][HTML] No apparent association between mRNA COVID-19 vaccination and venous thromboembolism

M Nicholson, H Goubran, N Chan, D Siegal - Blood Reviews, 2022 - Elsevier
By January 2022 over ten billion doses of COVID-19 vaccines had been administered
worldwide. Concerns about COVID-19 vaccine-associated thrombosis arose after the …

Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2

C Kim, JD Kim, SU Seo - Journal of Microbiology, 2022 - Springer
The global spread of coronavirus disease 2019 caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has provoked an urgent need for …